Cardiology care in China typically costs from $15,600 to $35,900. Final expenses depend on the hospital tier, the type of medical consumables used—such as specialized stents—and whether you choose a public facility or an international clinic. Patients can save approximately 40-60% compared to the US.
Typical Cardiology Costs in China
Major medical centers for cardiac care are found in Beijing and Shanghai, where prices at top-tier hospitals are often higher than in other regions. It is best to consult with a specialist to get accurate pricing for your specific medical needs.
| China | Turkey | Austria | |
| Transluminal Arterial Angioplasty (PTA) and Stenting | from $9,200 | from $2,000 | from $15,000 |
| Resveratrol IV Therapy | from $350 | from $200 | from $600 |
| Radiofrequency ablation with 3D mapping | from $16,500 | from $6,000 | from $13,000 |
| Radiofrequency ablation | from $8,500 | from $2,315 | from $15,000 |
| Pulmonary hypertension stem cell treatment | from $22,000 | from $12,000 | from $55,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Cardiology treatment upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Cardiology treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Cardiology treatment journey.
Dr. Shen Yuqin, MD, PhD, is Professor and Chief Physician at Shanghai Tongji Hospital. Dr. Shen directs the Rehabilitation Medicine Center and the Cardiac Rehabilitation Department. A doctoral supervisor and National Advanced Worker, Dr. Shen is a pioneer in cardiac rehabilitation for heart failure.
Dr. Shen was the first in China to implement cardiopulmonary exercise testing (CPET)-guided rehabilitation for heart failure. Dr. Shen also introduced the use of the anaerobic threshold to prescribe exercise intensity. The team created a nationwide hospital–community–home closed-loop model. In 2020, they opened Shanghai’s only inpatient cardiac rehabilitation ward in a tertiary hospital.
Dr. Shen is the principal investigator of two NSFC General Projects. Honors include the CRMA Science and Technology Award, First Prize (2019), and the Shanghai Rehabilitation Medicine Science and Technology Progress Awards, First Prize (2018, 2024). Dr. Shen has published over 50 papers as first or corresponding author. Dr. Shen served as chief editor of one monograph and associate editor of two. The portfolio includes 22 patents (15 authorized, including three invention patents) and five software copyrights. Nine technology transfers have been completed.
Dr. Shen is a Fellow of the American Association of Cardiovascular and Pulmonary Rehabilitation (FAACVPR) and a CDQI certified expert. Dr. Shen serves as an associate editor and editorial board member. Dr. Shen led the drafting of eight consensuses, guidelines, and standards, and organized 20 national courses. The center has served more than 10,000 patients. The care model has been extended across Shanghai and introduced in Yunnan.
Professor Liang Xiaoxiao is the Department Director and Chief Physician in Neurorehabilitation. She holds a master’s degree in neurology. She is skilled in neuromodulation for disorders of consciousness, cognition, and movement. Her focus includes cases from cerebrovascular disease, Parkinson’s disease, and related conditions. She also performs ultrasound-guided botulinum toxin injections for blepharospasm, hemifacial spasm, limb spasticity, sialorrhea, and neuralgia.
Accreditations and roles: Member of the Neurorehabilitation, Cognitive Disorder Rehabilitation, and Craniocerebral Trauma Rehabilitation Committees of the Chinese Association of Rehabilitation Medicine. Standing Member of the Cognitive Disorder Rehabilitation Committee of the Fujian Association of Rehabilitation Medicine. Vice Chair of the Dementia and Cognitive Disorder Committee of the Xiamen Preventive Medicine Association. Vice President of the Parkinson’s Disease and Movement Disorders Committee of the Xiamen Medical Doctor Association. Standing Member of the Neuromodulation Committee of the Xiamen Medical Doctor Association. Recipient of the Most Beautiful Physician of Xiamen City (2024).
Written by Kateryna Zamkovska
Top cardiology hospitals in China include Fuwai Hospital and Beijing Anzhen Hospital. These centers specialize in complex heart surgery and arrhythmia treatment. Leading facilities like Zhongshan Hospital in Shanghai offer advanced coronary care. Most top centers hold regional or national leadership status for cardiovascular research.
Bookimed Expert Insight: Data shows a clear geographic specialization trend for cardiac care in China. Beijing hospitals like Yanda International Hospital often manage higher patient volumes, exceeding 2,500,000 annually. This high turnover typically correlates with faster access to interventional cardiology procedures. Patients seeking complex surgeries often find shorter wait times in these high-capacity Class A Level III clinics.
Patient Consensus: Patients note that while medical results are excellent, top hospitals are often very crowded. It is important to request English discharge summaries before leaving to ensure easy follow-up care at home.
Advanced cardiac technologies in China include domestically developed implantable left ventricular assist devices and 5G-powered robotic surgery systems. Patients access transcatheter aortic valve replacement (TAVR) and AI-enhanced diagnostics. Top-tier hospitals perform complex interventions using satellite-guided telesurgery and specialized cardiovascular CT scanners for high-resolution imaging.
Bookimed Expert Insight: While many global patients focus on Beijing, Guangzhou clinics like Fuda Cancer Hospital demonstrate specialized expertise in vascular interventional therapy. JCI-accredited facilities often manage 30,000+ international patients. This volume allows these centers to refine protocols for complex cardiac cases faster than smaller regional clinics.
Patient Consensus: Patients note that major centers perform over 10,000 TAVR procedures annually. It is vital to arrange for professional interpreter services in advance to handle technical medical discussions during follow-up care.
Traditional Chinese Medicine (TCM) integrates with cardiac care in China for international patients. Major JCI-accredited facilities combine Western protocols with acupuncture and herbal formulas. These hybrid approaches manage chronic symptoms and improve recovery. Clinicians often use tai chi and herbs during post-operative cardiac rehabilitation programs.
Bookimed Expert Insight: Yanda International Hospital serves 2,500,000 patients annually and holds JCI accreditation for international safety. Our data shows it utilizes over 28,500 modern technologies while maintaining specialized traditional departments. This volume allows clinicians to refine hybrid protocols specifically for complex cases like congestive heart failure. Patients seeking this integration should focus on Class A Level III clinics in Beijing for the highest standards.
Patient Consensus: Patients note that state hospitals blend herbs and acupuncture into recovery. Some mention these hybrid methods help reduce the dosages of Western medications during long-term care.
International patients traveling for cardiology in China require a comprehensive medical assessment 4–6 weeks before arrival. This work-up includes a recent echocardiogram, angiogram results from the last 6 months, and a full coagulation panel. Doctors use these files during pre-arrival virtual consultations to confirm surgical candidacy.
Bookimed Expert Insight: High-capacity centers like Yanda International Hospital, which manages 2,500,000 patients annually, often merge international protocols with traditional approaches. Patients should secure an itemized hospital quote early. This document is essential for insurance pre-authorization. Most international plans will not cover cardiac procedures in China without this specific proof of medical necessity.
Patient Consensus: Patients emphasize the need for professional translations of all cardiac files into English or Chinese before travel. Many note that skipping a pre-arrival virtual consult often leads to frustrating treatment delays or mandatory re-testing upon arrival.